Alvotech (ALVO) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

ALVO Stock Forecast


Alvotech stock forecast is as follows: an average price target of $16.00 (represents a 23.84% upside from ALVO’s last price of $12.92) and a rating consensus of 'Hold', based on 3 wall street analysts offering a 1-year stock forecast.

ALVO Price Target


The average price target for Alvotech (ALVO) is $16.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $22.00 to $10.00. This represents a potential 23.84% upside from ALVO's last price of $12.92.

ALVO Analyst Ratings


Hold

According to 3 Wall Street analysts, Alvotech's rating consensus is 'Hold'. The analyst rating breakdown for ALVO stock is 0 'Strong Buy' (0.00%), 1 'Buy' (33.33%), 2 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Alvotech Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 24, 2024Balaji PrasadBarclays$22.00$13.5862.00%70.28%
May 21, 2024Balaji PrasadBarclays$20.00$13.7645.35%54.80%
Jan 29, 2024Balaji PrasadBarclays$17.00$15.2511.48%31.58%
Jul 01, 2022Emmanuel PapadakisDeutsche Bank$10.00$8.2121.80%-22.60%
Row per page
Go to

The latest Alvotech stock forecast, released on May 24, 2024 by Balaji Prasad from Barclays, set a price target of $22.00, which represents a 62.00% increase from the stock price at the time of the forecast ($13.58), and a 70.28% increase from ALVO last price ($12.92).

Alvotech Price Target by Period


1M3M12M
# Anlaysts--3
Avg Price Target--$19.67
Last Closing Price$12.92$12.92$12.92
Upside/Downside-100.00%-100.00%52.24%

In the current month, the average price target of Alvotech stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Alvotech's last price of $12.92. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
May 21, 2024BarclaysOverweightOverweightHold
Jan 29, 2024Barclays-OverweightUpgrade
Oct 20, 2023Citigroup-NeutralUpgrade
Jul 01, 2022Deutsche Bank-HoldInitialise
Row per page
Go to

Alvotech's last stock rating was published by Barclays on May 21, 2024. The company gave ALVO a "Overweight" rating, the same as its previous rate.

Alvotech Financial Forecast


Alvotech Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Jun 23
Revenue---------
Avg Forecast$89.86M$82.41M$75.59M$69.32M$115.50M$85.00M$53.48M$93.00M$42.00M
High Forecast$89.86M$82.41M$75.59M$69.32M$115.50M$89.16M$53.48M$93.00M$42.00M
Low Forecast$89.86M$82.41M$75.59M$69.32M$115.50M$80.83M$53.48M$93.00M$42.00M
# Analysts111112111
Surprise %---------

Alvotech's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. ALVO's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Alvotech EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Jun 23
# Analysts111112111
EBITDA---------
Avg Forecast$-89.86M$-82.41M$-75.59M$-69.32M$-115.50M$-85.00M$-53.48M$-93.00M$-42.00M
High Forecast$-89.86M$-82.41M$-75.59M$-69.32M$-115.50M$-80.83M$-53.48M$-93.00M$-42.00M
Low Forecast$-89.86M$-82.41M$-75.59M$-69.32M$-115.50M$-89.16M$-53.48M$-93.00M$-42.00M
Surprise %---------

undefined analysts predict ALVO's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Alvotech's previous annual EBITDA (undefined) of $NaN.

Alvotech Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Jun 23
# Analysts111112111
Net Income---------
Avg Forecast$25.43M$31.85M$12.57M$14.25M$2.79M$-16.76M$838.22K$11.74M$-39.12M
High Forecast$25.43M$31.85M$12.57M$14.25M$2.79M$-16.76M$838.22K$11.74M$-39.12M
Low Forecast$25.43M$31.85M$12.57M$14.25M$2.79M$-16.76M$838.22K$11.74M$-39.12M
Surprise %---------

Alvotech's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ALVO's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Alvotech SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Jun 23
# Analysts111112111
SG&A---------
Avg Forecast$139.83M$128.24M$117.62M$107.87M$179.73M$132.27M$83.22M$144.72M$65.36M
High Forecast$139.83M$128.24M$117.62M$107.87M$179.73M$138.73M$83.22M$144.72M$65.36M
Low Forecast$139.83M$128.24M$117.62M$107.87M$179.73M$125.79M$83.22M$144.72M$65.36M
Surprise %---------

Alvotech's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to ALVO last annual SG&A of $NaN (undefined).

Alvotech EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Jun 23
# Analysts111112111
EPS---------
Avg Forecast$0.09$0.11$0.04$0.05$0.01$-0.06-$0.04$-0.14
High Forecast$0.09$0.11$0.04$0.05$0.01$-0.06-$0.04$-0.14
Low Forecast$0.09$0.11$0.04$0.05$0.01$-0.06-$0.04$-0.14
Surprise %---------

According to undefined Wall Street analysts, Alvotech's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ALVO previous annual EPS of $NaN (undefined).

Alvotech Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ASRTAssertio$1.06$2.88171.70%Buy
PCRXPacira BioSciences$16.45$40.00143.16%Hold
ANIPANI Pharmaceuticals$56.01$79.0041.05%Buy
AMPHAmphastar Pharmaceuticals$50.59$66.0030.46%Buy
CTLTCatalent$58.69$76.4030.18%Hold
CYTHCyclo Therapeutics$0.73$0.9530.14%Buy
ALKSAlkermes$26.59$34.3829.30%Hold
COLLCollegium Pharmaceutical$32.72$41.5026.83%Buy
ALVOAlvotech$12.92$16.0023.84%Hold
ITCIIntra-Cellular Therapies$86.17$94.509.67%Buy
LFCRLifecore Biomedical$5.99$6.508.51%Buy

ALVO Forecast FAQ


No, according to 3 Wall Street analysts, Alvotech (ALVO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 33.33% of ALVO's total ratings.

Alvotech (ALVO) average price target is $16 with a range of $10 to $22, implying a 23.84% from its last price of $12.92. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for ALVO stock, the company can go up by 23.84% (from the last price of $12.92 to the average price target of $16), up by 70.28% based on the highest stock price target, and down by -22.60% based on the lowest stock price target.

ALVO's highest twelve months analyst stock price target of $22 supports the claim that Alvotech can reach $20 in the near future.

Alvotech's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $253.98M (high $258.14M, low $249.82M), average EBITDA is $-254M (high $-250M, low $-258M), average net income is $-13.132M (high $-13.132M, low $-13.132M), average SG&A $395.22M (high $401.68M, low $388.73M), and average EPS is $-0.047 (high $-0.047, low $-0.047). ALVO's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $317.18M (high $317.18M, low $317.18M), average EBITDA is $-317M (high $-317M, low $-317M), average net income is $84.1M (high $84.1M, low $84.1M), average SG&A $493.56M (high $493.56M, low $493.56M), and average EPS is $0.301 (high $0.301, low $0.301).